Adrenomedullin related to the clinical severity in patients with HF and can be considered as a prognostic mater in chronic HF patients While it perhaps premature to speculate whether modulating adrenomedullin levels will translate into clinical improvement in morbidity and mortality for pediatric patients with chronic heart failure.